The Cigna Group (NYSE:CI) Tops Q3 2025 Revenue Forecasts, Misses on EPS

The Cigna Group (NYSE:CI) reported financial results for the third quarter of 2025 that surpassed analyst revenue expectations, though its adjusted earnings per share came in slightly below consensus estimates. The performance has elicited a muted but positive initial reaction in pre-market trading.

Third Quarter Performance Versus Estimates

The company's top-line strength was the standout feature of the quarter, demonstrating robust growth and exceeding forecasts. The bottom-line result, while a solid figure, narrowly missed the mark set by Wall Street.

• Revenue: The Cigna Group reported revenue of $69.57 billion for Q3 2025. This represents a significant increase compared to the prior year and came in above the analyst consensus estimate of approximately $69.12 billion.
• Adjusted Earnings Per Share (EPS): The company posted a non-GAAP profit of $7.83 per share. This was a strong result but fell just short of the $7.88 per share that analysts had projected.

Market Reaction and Recent Price Action

The market's immediate response to the mixed earnings beat has been cautiously optimistic. The stock is trading higher in the pre-market session, indicating that investors may be focusing on the revenue outperformance and the company's reaffirmed outlook. This positive movement contrasts with the stock's performance over the past week, which saw a slight decline. Over the past month, however, the stock has maintained a modest upward trajectory, suggesting a degree of stability leading into the earnings announcement.

Strategic Execution and Reaffirmed Outlook

According to the company's press release, the strong quarterly results reflect successful strategic execution across its diverse portfolio of businesses, which includes its Evernorth Health Services and Cigna Healthcare platforms. A key takeaway for investors is management's decision to reaffirm its full-year 2025 adjusted EPS outlook. This provides a signal of confidence in the company's ability to meet its annual targets despite the slight EPS miss in the third quarter. The press release also highlighted that total revenues for the quarter increased by 10% year-over-year to $69.7 billion.

Looking Ahead

With the third quarter results now public, investor attention will shift to the company's ability to meet expectations for the remainder of the year. Analyst estimates for the critical fourth quarter of 2025 project revenue of approximately $70.17 billion. The company's reaffirmed guidance will be closely watched against these external forecasts as the year concludes.

For a detailed breakdown of historical earnings, future estimates, and analyst projections, you can review the data available on the Cigna earnings and estimates page.

Disclaimer: This article is for informational purposes only and does not constitute investment advice of any kind.